Commonwealth Equity Services LLC Purchases 29,903 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Commonwealth Equity Services LLC increased its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 35.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 113,563 shares of the health services provider’s stock after buying an additional 29,903 shares during the quarter. Commonwealth Equity Services LLC owned 0.07% of Teladoc Health worth $1,032,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of TDOC. Point72 Asset Management L.P. boosted its stake in Teladoc Health by 57.8% in the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after purchasing an additional 3,063,172 shares during the period. Maple Rock Capital Partners Inc. bought a new stake in Teladoc Health in the 3rd quarter valued at $11,291,000. Invenomic Capital Management LP lifted its stake in Teladoc Health by 155.2% in the 3rd quarter. Invenomic Capital Management LP now owns 1,474,337 shares of the health services provider’s stock worth $13,534,000 after purchasing an additional 896,552 shares in the last quarter. Nisa Investment Advisors LLC boosted its holdings in shares of Teladoc Health by 20,936.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock valued at $3,874,000 after purchasing an additional 424,180 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Teladoc Health by 18.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock valued at $22,213,000 after purchasing an additional 384,528 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Insiders Place Their Bets

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. This represents a 14.62 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.95% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

TDOC has been the topic of a number of research analyst reports. Royal Bank of Canada boosted their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Oppenheimer decreased their price objective on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Piper Sandler cut their target price on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. The Goldman Sachs Group decreased their price target on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday, March 3rd. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Eleven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, Teladoc Health currently has an average rating of “Hold” and an average target price of $11.26.

Teladoc Health Stock Performance

TDOC stock opened at $7.97 on Tuesday. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $15.27. The firm has a market cap of $1.38 billion, a price-to-earnings ratio of -1.38 and a beta of 1.27. The business’s fifty day simple moving average is $10.32 and its two-hundred day simple moving average is $9.81. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million during the quarter, compared to analysts’ expectations of $639.44 million. Analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.